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Abstract
Introduction: The influenza virus infection may be severe in non-immune people. Common complications of
influenza virus include upper and lower respiratory tract infections, otitis media, myocarditis, acute respiratory
distress syndrome and multi-organ failure. There have been cases of vasculitis following influenza vaccination, and
rash and acute purpura may occur in certain viral infections. To the best of our knowledge, there are no reports
concerning cases of systemic vasculitis associated with pandemic 2009 (H1N1) infection.
Case presentation: A 23-year-old Caucasian woman was hospitalized at the “L. Spallanzani” National Institute for
Infectious Diseases in Rome, Italy. Clinical and radiological features including laboratory findings of this case are
illustrated. Notably, the patient had fever, severe abdominal pain, hematuria, arthritis, and purpuric manifestations
associated with a normal platelet count. Nasopharyngeal and rectal swabs revealed pandemic 2009 (H1N1) virus by
reverse-transcriptase-polymerase-chain-reaction assay. Routine laboratory analyses showed elevated inflammatory
parameters. The autoimmune panel tests were normal. Steroid therapy associated with oseltamivir achieved an
evident and rapid improvement. On day seven the patient chose to leave the hospital against medical advice.
Conclusion: Complications related to influenza infection can be life threatening, particularly in
immunocompromised patients. Henoch-Schönlein purpura triggered by the novel influenza virus infection could
be an attractive pathogenetic hypothesis. We have discussed both the diagnosis and the challenge of therapy
protocols. Steroid therapy is part of the management of severe vasculitis. Our case suggests that steroid therapy
associated with antivirals can prevent the risk of further complications such as hemorrhage and multi-organ failure
during severe vasculitis, without enhancing the virulence of the influenza virus. The possible role of pandemic 2009
(H1N1) in the pathogenesis of hemorrhagic manifestations should be further investigated.
Introduction
No cases of vasculitis were ever reported during the
pandemic 2009 H1N1 (2009 H1N1) infection, thus its
occurrence can be considered rare with undetermined
etiology. Systemic vasculiti sh a sb e e nd e s c r i b e da sa n
extremely rare event during influenza infection or fol-
lowing the administration of vaccines [1-4]. In addition,
influenza infection has seldom been associated with var-
ious autoimmune diseases [5]. Among viral respiratory
diseases, adenovirus and enteroviruses were previously
identified in patients with the onset of rash and cuta-
neous vasculitis [2,6]. Pandemic 2009 H1N1 had a broad
clinical spectrum. The majority of 2009 H1N1 infections
are mild and self limiting; however, since the virus can
cause serious respiratory disorders in young people and
lead to severe complications in non-immune people,
early treatment is recommended [7]. In the spring of
2009, the 2009 H1N1 virus spread rapidly throughout
the world. The authors describe a case of systemic vas-
culitis that occurred in an Australian woman suffering
from 2009 H1N1 infection. She was hospitalized at the
“L. Spallanzani” National Institute for Infectious Dis-
eases (INMI).
Case presentation
A 23-year-old Caucasian woman spending her holidays
in Italy was admitted to INMI in Rome. The otherwise
healthy patient presented with a two-day history of
fever, severe abdominal pain, diarrhoea with bloody
stools and haemorrhagic skin lesions.
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and a cough. She had received the first dose of human
papillomavirus vaccination one month prior to her
admittance. On examination, the patient looked pale,
tired and feverish with a body temperature of 38.8°C.
She manifested an extension of haemorrhagic purpura
all over her limbs (Figure 1) and complained of severe
abdominal pain. Nasopharyngeal and rectal swabs evi-
denced a 2009 H1N1 virus by reverse-transcriptase poly-
merase chain reaction (RT-PCR) assay. Her blood count
showed mild anaemia (haemoglobin, 11.70 g/dl), neutro-
philia (white blood cells 15.700/mmc: neutrophils
13.400/mmc (85.1%), lymphocytes 1.200/mmc (7,7%),
monocytes 800/mmc). C-reactive protein (2.70 mg/dl)
and Dimer test values (4.788 ng/dl) were elevated. Plate-
let count, clotting tests and ESR were normal. A urine
examination showed proteinuria, red cells, leukocytes,
hyaline and erythrocyte casts. Specific laboratory tests
were performed ruling out immunological and autoim-
mune disorders, including anti-nuclear antibody profile
(autoantibodies against RNP/Sm, SS-A, Ro-52, SS-B,
Scl-70, Jo-1, centromere B, dsDNA, histones, anti-mito-
chondrial M2 antibody), anti-smooth muscle, anti-liver-
kidney microsomal antibodies, anti-platelets, anti-gastric
parietal cell, anti-cardiolipin IgG and IgM, anti-neutro-
philic cytoplasmic antibodies (ANCA), lupus anticoagu-
lant, rheumatoid factor (RF), and Coombs test.
Serological tests ruled out acute bacterial or viral infec-
tions including Brucella species, Salmonella species,
Rickettsia conori, Coxiella burneti or viruses such as
dengue, cytomegalovirus, Epstein-Barr virus, herpes sim-
plex, HIV, coxsackievirus, echovirus and adenovirus.
Bacterial nasopharyngeal, blood and urine cultures were
sterile. Chest and abdomen X-rays were normal. A com-
puted tomography (CT)-scan of her abdomen and pelvis
without contrast revealed only a small effusion in the
pouch of Douglas. Oseltamivir (75 mg twice a day,
orally) and ciprofloxacin (400 mg twice a day, intrave-
nously) were administered. A short course of methyl-
prednisolone was administered intravenously, starting at
40 mg on July 15 and then reduced by 10 mg daily until
it was withdrawn on July 20. Her clinical condition
Figure 1 Overview of the features of purpura before treatment. A, C: show an overview of the features of purpura before treatment.
B: details the hemorrhagic-necrotic skin lesions on the feet, associated with petechial lesions on the lateral part of the right foot.
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kocytosis decreased (white blood cells 10.100/mmc, neu-
trophils 5.600/mmc, lymphocytes 3600/mmc). The fever
disappeared in three days, her abdominal pain was
resolved and there was a marked improvement in the
vasculitic lesions. On Day seven she chose to leave the
hospital against medical advice.
Discussion
The rash that can occur during influenza virus infection
usually has a macular or maculopapular aspect and can
be confused with measles. Hope-Simpson and Higgins
[8] found that approximately 8% of influenza B infec-
tions and 2% of influenza A vir u si n f e c t i o n sa r ea s s o -
ciated with rash. In addition, Silva and others [1]
described a case of a child with a febrile petechial rash
associated with influenza A virus infection.
Although cases of vasculitis have occurred following
influenza vaccination [3,4], to our knowledge there are
no reports concerning cases of systemic vasculitis asso-
ciated with the 2009 H1N1 infection. An immune
thrombocytopenic purpura following human papilloma-
virus vaccination has been reported [9]. Other vasculitic
conditions and sepsis were excluded.
The etiology of Henoch-Schönlein purpura (HSP),
which is a systemic vasculitis described mainly in child-
hood (0.013 to 0.02%), actually remains unknown [10]. In
our case, the skin and abdominal haemorrhagic manifes-
tations associated with a normal platelet count could be
related to both the 2009 H1N1 infection and HSP. Strep-
tococcal, Mycoplasma species, adenovirus, parvovirus
and coxsackievirus infections have been reported to pre-
cede HSP [10]. In our case, an upper respiratory tract
infection occurred first. The main diagnostic hallmarks
of HSP include clinical and histological features. In this
case the clinical features of HSP such as fever, purpuric
rash, bloody stools, hematuria, abdominal pain, joints
and kidney involvement, and normal platelet count were
present. We did not perform a biopsy of the skin lesions
because of the voluntary discharge of the patient.
Vasculitis may result from the interaction between
influenza virus antigen A H1N1 and the host’s immune
response. It has been hypothesized as being a pathoge-
netic immune-mediated mechanism induced by infec-
tions [10,11]. Deregulation of cytokine biosynthesis has
been considered the fundamental pathogenetic mechan-
ism related to the severity and progression of 2009
H1N1 influenza [12]. Particularly, the secretion of Th1
and Th17 cytokines was reported as an early host
response in severe 2009 H1N1 infection [13] and it is
well known that these cytokines are also involved in
inflammatory and autoimmune responses [14]. The pro-
inflammatory immune response may facilitate the occur-
rence of vasculitis during a severe pandemic infection.
The spectrum of treatment against vasculitis during
influenza infection has been broadly discussed. Steroid
therapy was not absolutely contraindicated during 2009
H1N1 infection as reported in the scientific literature.
Quispe-Laime and others reported that in patients with
H1N1 influenza affected by severe respiratory complica-
tions, treatment with a prolonged, moderate dose of
corticosteroids was associated with significant improve-
ment in lung injury, multiple organ function scores and
low hospital mortality [15]. Carter MJ et al. argued that
steroids can have an additional role to antiviral therapy
in the treatment of severe cases of H5N1 avian flu [13].
In our case, on the basis of a high clinical suspicion of
severe vasculitis syndrome and considering the rapid
impairment of the clinical conditions, a short-course of
steroid therapy was added to the antiviral drugs. Despite
the steroid therapy, by Day 6 the nasopharyngeal swab
did not show evidence of the presence of 2009 H1N1
virus by RT-PCR. Randomized clinical trials are needed
to determine whether additional steroid treatment could
be beneficial to dominate spreading of the cytokines,
which occurs in severe pandemic H1N1 influenza.
Conclusion
Systemic vasculitis associated with 2009 H1N1 infection
is extremely rare. In this case, the role of the 2009
H1N1 influenza virus in the pathogenesis of hemorrha-
gic manifestations should be considered. The lack of a
histopathological study of the skin lesions may limit our
conclusions; however, the macroscopic characteristics of
the purpura suggest a vasculitic process. Overall, the
clinical, immunological and radiological features are
consistent with the clinical diagnosis of HSP. In our
case, a short course of steroid therapy in addition to
antivirals did not delay the clearance of 2009 H1N1
virus and the combined treatment contributed to
improving a complicated case of vasculitis.
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